Download PDF
Thromb Haemost 1966; 16(01/02): 069-085
DOI: 10.1055/s-0038-1655628
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

The Influence of Human Blood Cells on the Solubility of Clot in Urea Solution and Clot Lysis

St Kirchmayer
1   II-nd Clinic of Internal Medicine (Director: Assoc. Prof. Dr. Stanislaw Kirchmayer), and the Department of Physiological Chemistry (Director: Assoc. Prof. Dr. Wlodzimierz Ostrowski), Medical Academy, Cracow
,
A Koj
1   II-nd Clinic of Internal Medicine (Director: Assoc. Prof. Dr. Stanislaw Kirchmayer), and the Department of Physiological Chemistry (Director: Assoc. Prof. Dr. Wlodzimierz Ostrowski), Medical Academy, Cracow
,
B Biernacka
1   II-nd Clinic of Internal Medicine (Director: Assoc. Prof. Dr. Stanislaw Kirchmayer), and the Department of Physiological Chemistry (Director: Assoc. Prof. Dr. Wlodzimierz Ostrowski), Medical Academy, Cracow
› Author Affiliations
Further Information

Publication History

Publication Date:
26 June 2018 (online)

Also available at
    Permissions and Reprints

Summary

A proteolytic factor digesting fibrin in concentrate urea solution was demonstrated in granulocytes, erythrocytes and blood platelets.

The proteolytic factor is not dialysable, is inactivated at temp. 80°, and produces low molecular weight peptides when digesting clot. Its action on fibrin is dependent on the presence of urea, but urea does not activate it permanently. In granulocytes the factor is present in an active form, and in red blood cells it is located in the stromata, its activity being suppressed by an inhibitor adsorbed on the surface of the cells. Red blood cells exhibit proteolytic activity only after several washings with physiological saline solution.

Increased solubility of full blood clots in urea can be brought about by addition of an excess of active proteolytic factor (concentrated granulocyte or washed red blood cell suspensions) to the clot, or by prior washing of the clot with physiological saline (to remove the inhibitor). Noncellular clots (fibrin, plasma clots) may be dissolved in urea only after addition of granulocytes, platelets or activated red cells.

The possible role of this proteolytic activity in the in vivo liquefaction of blood clots is discussed.

 

  • References

  • 1 Bernhart M, Riddle J. M. Cellular Localisation of Proñbrinolisin. Blood 21: 306-321 1963;
    PubMedGoogle Scholar
  • 2 Buluk K, Januszko T, Olbromski J, Smarza M, Gudnik M. Krwinkowy stabilizator wlóknika. Postçpy. Hig. Med. Dosw 17: 743-750 1963;
    PubMedGoogle Scholar
  • 3 Buluk K, Kowarzyk H. In: S. Niewiarowski, Krzepniçcie Krwi. Warszawa 1954, PZWL
    PubMed
  • 4 Caviezel O, Vollery M, Vanotti A. Fibrynolyse leucocytaire. Schweiz, med. Wschr 94: 1017-1019 1964;
    PubMedGoogle Scholar
  • 5 Gans R. Fibrynolitic properties of proteases derived from human, dog and rabbit leukocytes. Thrombos. Diathes. haemorrh. (Stuttg.) 10: 379-389 1964;
    PubMedGoogle Scholar
  • 6 Greenberg D. M. In: Methods in Enzymology. Golowick S. P, and Kaplan N. O. Vol II 55 Acad. Press; N. Y.: 1955
    Google Scholar
  • 7 Izraelewicz D. Sur la méthode de preparation du stroma etythrocytaire. C. K. Soc. Biol. (Paris) 155: 2177-2178 1961;
    PubMedGoogle Scholar
  • 8 Jühling L, Wöhlisch E. Über Fibrynogenolyse unter den Einfluß hydrotroper Substanzen. Biochem. Z 298: 312-315 1938;
    PubMedGoogle Scholar
  • 9 vonK aulla K. N, Smith R. L. Urea derivatives as flbrynolysis promoting agents. Proc. Soc. exp. Biol. (N. Y.) 106: 530-532 1961;
    CrossrefPubMedGoogle Scholar
  • 10 Kirchmayer S, Koj A, Biernacka B. Badania nad rozpuszczalnoscia, w moczniku skrzepu krwi chorych z przewlekłą białaczką, szpikową. Przegl. lek 21 II 533-540 1964;
    PubMedGoogle Scholar
  • 11 Kolmon S. N, Guest M. M, Geländer D. R. Evidence for the adsorption upon erythrocytes of urokinase and other components of the fibrinolytic system. Arch. Biochem 85: 334-336 1959;
    CrossrefPubMedGoogle Scholar
  • 12 Kotschy M, Jacobsen C. D. Slight influence of erythrocytes and hemolysate on fibrinolysis in vitro. Scand. J. clin. Lab. Invest 16: 55-60 1964;
    CrossrefPubMedGoogle Scholar
  • 13 Künzer W, Haberhausen A. Fibrynolytic activity of human erythrocytes. Nature (Lond.) 198: 396 1963;
    CrossrefPubMedGoogle Scholar
  • 14 Laki K, Lorand L. On the solubility of fibrin clots. Science 108: 280 1948;
    CrossrefPubMedGoogle Scholar
  • 15 Loewy A. G, Dahlberg A, Dunathan K, Kriel R, Wolfinger H. L. Fibrinase. Some physical properties. J. biol. Chem 236: 2634-2643 1961;
    PubMedGoogle Scholar
  • 16 Lorand L, Jacobson A. Studies on the polymerisation of fibrin. The role of the globulin; Fibrin Stabilizing Factor. J. biol. Chem 230: 421-434 1958;
    PubMedGoogle Scholar
  • 17 Tyminski M, Czçstochowska E. O czynnikach krwinkowych wplywaja_cych na fibrynolizç. Postçpy Hig. Med. Dosw 16: 1119-1123 1962;
    PubMedGoogle Scholar
  • 18 Weiss H. J. Increased urea solubility of the blood clot in chronic granulocytic leukemia and its relation to the abnormal thromboelastogram. Acta haemat. (Basel) 30: 326-333 1963;
    CrossrefPubMedGoogle Scholar